158 related articles for article (PubMed ID: 1977505)
1. New H1-receptor antagonists: clinical pharmacology.
Simons FE
Clin Exp Allergy; 1990 Aug; 20 Suppl 2():19-24. PubMed ID: 1977505
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in H1-receptor antagonist treatment.
Simons FE
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):995-9. PubMed ID: 1979802
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.
Simons FE; Simons KJ
Clin Pharmacokinet; 1991 Nov; 21(5):372-93. PubMed ID: 1685361
[TBL] [Abstract][Full Text] [Related]
4. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
Soter NA
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011
[TBL] [Abstract][Full Text] [Related]
5. The comparative pharmacokinetics of H1-receptor antagonists.
Simons FE; Simons KJ; Chung M; Yeh J
Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
[TBL] [Abstract][Full Text] [Related]
6. H1 receptor antagonist treatment of chronic rhinitis.
Simons FE; Simons KJ
J Allergy Clin Immunol; 1988 May; 81(5 Pt 2):975-80. PubMed ID: 2897389
[TBL] [Abstract][Full Text] [Related]
7. H1-receptor antagonist treatment of seasonal allergic rhinitis.
Kaiser HB
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1000-3. PubMed ID: 1979793
[TBL] [Abstract][Full Text] [Related]
8. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
Wiseman LR; Faulds D
Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of new histamine H1 receptor antagonists.
Simons FE; Simons KJ
Clin Pharmacokinet; 1999 May; 36(5):329-52. PubMed ID: 10384858
[TBL] [Abstract][Full Text] [Related]
10. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist].
Molkhou P
Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and pharmacodynamics of terfenadine in children.
Simons FE; Watson WT; Simons KJ
J Allergy Clin Immunol; 1987 Dec; 80(6):884-90. PubMed ID: 2891738
[TBL] [Abstract][Full Text] [Related]
12. Variations among non-sedating antihistamines: are there real differences?
Mattila MJ; Paakkari I
Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
[TBL] [Abstract][Full Text] [Related]
13. Second-generation H1-receptor antagonists.
Simons FE; Simons KJ
Ann Allergy; 1991 Jan; 66(1):5-16, 19. PubMed ID: 1670985
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Delgado LF; Pferferman A; Solé D; Naspitz CK
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
[TBL] [Abstract][Full Text] [Related]
15. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
Kaliner MA
Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of antihistamines.
Woodward JK
J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 2):606-12. PubMed ID: 1977782
[TBL] [Abstract][Full Text] [Related]
17. Second-generation antihistamines: a comparative review.
Slater JW; Zechnich AD; Haxby DG
Drugs; 1999 Jan; 57(1):31-47. PubMed ID: 9951950
[TBL] [Abstract][Full Text] [Related]
18. The new H1 antihistamines. Treatment of urticaria and other clinical problems.
Goldsmith P; Dowd PM
Dermatol Clin; 1993 Jan; 11(1):87-95. PubMed ID: 8094649
[TBL] [Abstract][Full Text] [Related]
19. Nonsedating histamine H1-receptor antagonists.
Mann KV; Crowe JP; Tietze KJ
Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
